Betagenon Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Betagenon General Information
Description
Developer of AMP-activated protein kinase (AMPK) activator compounds based in Umea, Sweden. The company is a biopharmaceutical specialisit that focuses on the development of AMPK activator compounds, to treat chronic energy balance disorders and diseases in metabolically challenged elderly and obese individuals.
Contact Information
Website
www.betagenon.comCorporate Office
- Västra Strandgatan 9B
- 903 26 Umea
- Sweden
Corporate Office
- Västra Strandgatan 9B
- 903 26 Umea
- Sweden
Betagenon Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Betagenon Patents
Betagenon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026117736-A1 | Combination therapies | Pending | 27-Nov-2024 | ||
| WO-2025252672-A1 | Use of tryptophan and metabolites thereof as biomarkers for treatment methods | Pending | 03-Jun-2024 | ||
| JP-2026531750-A | Cancer treatment with the pdk inhibitor 4-chloro-n-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazole-5-yl)benzamide | Pending | 03-Aug-2023 | ||
| EP-4753704-A1 | Treatment of cancer with the pdk inhibitor 4-chloro-n-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide | Pending | 03-Aug-2023 | ||
| WO-2025027205-A1 | Treatment of cancer with the pdk inhibitor 4-chloro-n-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide | Inactive | 03-Aug-2023 | A61K31/433 |
Betagenon Signals
Betagenon Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Betagenon FAQs
-
When was Betagenon founded?
Betagenon was founded in 2001.
-
Where is Betagenon headquartered?
Betagenon is headquartered in Umea, Sweden.
-
What is the size of Betagenon?
Betagenon has 1 total employees.
-
What industry is Betagenon in?
Betagenon’s primary industry is Drug Discovery.
-
Is Betagenon a private or public company?
Betagenon is a Private company.
-
What is the current valuation of Betagenon?
The current valuation of Betagenon is .
-
What is Betagenon’s current revenue?
The current revenue for Betagenon is .
-
How much funding has Betagenon raised over time?
Betagenon has raised $5M.
-
Who are Betagenon’s investors?
Fort Knox, Ivy Capital (Shanghai), MCG Global Technology, and The Kempe Foundations have invested in Betagenon.
-
When was Betagenon acquired?
Betagenon was acquired on 14-Mar-2023.
-
Who acquired Betagenon?
Betagenon was acquired by Amplifier Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process